Back to results
US 2004/0081682 A1Published application
Transdermal system (tds) that contain inhibitors of phosphodiesterase lV
OwnerClemes Guenther, Ralph Lipp +1inventors
InventorsClemes Guenther, Ralph Lipp, Fred Windt
Life of this patent
Estimating the term…
Abstract
The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (−) rolipram or (R)-(−)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone.
Claims12
Transdermal system exhibiting a content of a phosphodiesterase IV inhibitor, characterized in that the phosphodiesterase IV inhibitor is present in a matrix or in a reservoir system and in that the phosphodiesterase IV inhibitor is selected from the group below:
- (R)-(−)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone, in which the alkyl group contains 1 to 5 carbon atoms, or (R)-(−)-4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone) ((−)-rolipram).
Dependencies are inferred from the claim text.